no weight loss on compounded semaglutide Insurance said no. That doesn't mean you're out of options. Most plans don't cover for The FDA's Decision to Ban

The most commonly reported adverse event across all groups was GI distress (nausea, constipation, abdominal pain, diarrhea)

In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]

I am always open to questions, comments, and suggestions

Each batch is produced according to the compounding pharmacy's own protocols, tested by their own quality control processes (or third-party labs they select), and released based on their own standards